2025 Spring International Convention of
The Pharmaceutical Society of Korea

2025 Spring
International Convention of PSK

04.21(MON) - 04.22(TUE)
D+25

Abstracts

P7-9

Alleviating effect on osteoporosis of QOG through regulate PKM signalilg pathway in experimental osteoporosis model

 

  • Eun-Nam Kim1, Min Kyun Na1, Gil-Saeng Jeong*1
  • 1College of Pharmacy, Chungnam National University

A breakdown in bone homeostasis due to excessive osteoclast differentiation can lead to os-teo-porosis, and regulation of osteoclast differentiation has been known to be an important treatment strategy for osteoporosis. PKM2 is an enzyme that mainly generates pyruvate in gly-colysis, and plays an important role in metabolic regulation and cell signaling. Recent studies have revealed that PKM2 is an important link in bone metabolism and bone formation. In this study, we demonstrated that QOG, a natural product-derived compound, can act as an important mediator of bone formation and bone resorption, and demonstrated osteoporosis alleviation effects through regulation of the PKM2 signaling pathway in experimental in vitro and in vivo models.


Q&A

작성하기
  • There are no registered questions
TODAY 2025. 05. 17

2025 Spring Convention

D+25

Conference infomation

Conference Schedule
Apr. 21(Mon) ~ 22(Tue), 2025
Conference Venue
Daegu Exhibition & Convention Center (EXCO) 10 Exco-ro, Buk-gu, Daegu, Republic of Korea
Location
Early Registration Period
Feb. 24(Mon) ~ Apr. 14(Mon), 2025
Abstract Submission Period
Feb. 24(Mon) ~ Apr. 3(Thu), 2025
Certificate of Attendance